Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1002309-96-7

1002309-96-7

Post Buying Request

1002309-96-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1002309-96-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1002309-96-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,2,3,0 and 9 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1002309-96:
(9*1)+(8*0)+(7*0)+(6*2)+(5*3)+(4*0)+(3*9)+(2*9)+(1*6)=87
87 % 10 = 7
So 1002309-96-7 is a valid CAS Registry Number.

1002309-96-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(4-bromo-2-chlorophenyl)ethan-1-ol

1.2 Other means of identification

Product number -
Other names 1-(4-bromo-2-chlorophenyl)ethanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1002309-96-7 SDS

1002309-96-7Relevant articles and documents

METHODS AND COMPOSITIONS FOR TREATING HIV-RELATED DISORDERS

-

Paragraph 0225, (2016/02/10)

Certain adjunctive therapies comprising a kynurenine-3-monooxygenase inhibitor and an antiviral agent for treating HIV-related disorders are provided herein. These disorders include AIDS dementia complex, AIDS-induced encephalopathy, HIV-associated neurocognitive disorder, asymptomatic neurocognitive impairment, minor neurocognitive disorder, minor cognitive motor disorder, vacuolar myelopathy, peripheral neuropathies, and polymyositis. Also provided are pharmaceutical compositions comprising a kynurenine-3- monooxygenase inhibitor and an antiviral agent.

Modulators of methyl modifying enzymes, compositions and uses thereof

-

, (2015/12/26)

Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.

KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

-

Paragraph 00276, (2013/03/28)

Certain chemical entities are provided herein. Also provided are pharmaceutical compositions comprising at least one chemical entity and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and diso

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1002309-96-7